Management of the Axilla in the Era of Breast Cancer Heterogeneity - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Frontiers in Oncology Année : 2018

Management of the Axilla in the Era of Breast Cancer Heterogeneity

Résumé

Systemic cancer therapies take into account breast cancer (BC) heterogeneity by targeting pathways specifically involved in some BC subtypes. On the other hand, BC intrinsic radiosensitivity is poorly understood and studied. Hence, radiotherapy personalization in BC is still "work in progress". In this review, we will summarize the existing data on the management of axillary lymph nodes in BC, the impact of BC radiotherapy on axillary management, the indications for axillary radiotherapy, and biomarkers to predict patients' outcome (tumor control and late toxicities) after axillary irradiation.
Fichier principal
Vignette du fichier
fonc-08-00084.pdf (122.43 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-02281662 , version 1 (09-09-2019)

Identifiants

Citer

Maïlys de Meric de Bellefon, Claire Lemanski, Angélique Ducteil, Pascal Fenoglietto, David Azria, et al.. Management of the Axilla in the Era of Breast Cancer Heterogeneity. Frontiers in Oncology, 2018, 8, pp.84. ⟨10.3389/fonc.2018.00084⟩. ⟨hal-02281662⟩
61 Consultations
74 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More